| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA709157 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intraperitoneally for optimal dose | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 2. | ALA709158 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intravenously for optimal dose | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA879505 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intraperitoneally for percent T/C | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA709159 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intravenously for percent T/C | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA709160 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intraperitoneally for total dose. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA709161 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intravenously for total dose. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 7. | ALA709162 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intraperitoneally for toxicity related death. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA709163 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intravenously for toxicity related death. | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA709011 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intraperitoneally for median tumor burden | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA709012 | F | Compound was evaluated in vivo for antitumor activity against M5076 after injecting the compound intravenously for median tumor burden | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA709013 | F | Antitumor activity against murine tumor cells M5076 in BDF1 mice administered 0.8 mg/Kg intraperitoneally on days 1,5, and 9 relative to tumor inoculation | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 12. | ALA709014 | F | Antitumor activity against murine tumor cells M5076 in BDF1 mice administered 1.6 mg/kg intraperitoneally on days 1,5, and 9 relative to tumor inoculation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA703652 | F | Antitumor activity against murine tumor cells M5076 in BDF1 mice administered 25 mg/kg intraperitoneally on days 1,5, and 9 relative to tumor inoculation | Mus musculus | 2 | organism-based format | Scientific Literature | ||
| 14. | ALA703653 | F | Antitumor activity against murine tumor cells M5076 in BDF1 mice administered 3 mg/Kg intraperitoneally on days 1,5, and 9 relative to tumor inoculation | Mus musculus | 1 | cell-based format | Scientific Literature | ||
| 15. | ALA703654 | F | Antitumor activity against murine tumor cells M5076 in BDF1 mice administered 3 mg/kg intraperitoneally on days 1,5, and 9 relative to tumor inoculation | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA703655 | F | Antitumor activity expressed percentage increase in life span was determined against inoculated M5076 Ovarian Carcinoma in mice by 22.5 mg/kg dosage of compound (qd3hx8), for days 1,4,7,10 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA703656 | F | Antitumor activity expressed percentage increase in life span was determined against inoculated M5076 Ovarian Carcinoma in mice by 22.5 mg/kg dosage of compound (qd3hx8), for days 1,4,7,10,13,16 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA703657 | F | Antitumor activity expressed percentage increase in life span was determined against inoculated M5076 Ovarian Carcinoma in mice by 22.5 mg/kg dosage of compound (qd3hx8), for days 1,4,7,15,18,21 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA703658 | F | Antitumor activity expressed percentage increase in life span was determined against inoculated M5076 Ovarian Carcinoma in mice by 11.3 mg/kg dosage of compound (qd3hx8), for days 1,4,7,10 | Mus musculus | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA703659 | F | Antitumor activity was evaluated by measuring mean life span in tumor (M5076) inoculated mice at 11.3 mg/kg (qd3hx8),days 1,4,7,10 | Mus musculus | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!